Browsing by Author "Liles, Darla"
-
Comparing the Effectiveness of Education Versus Digital Cognitive Behavioral Therapy for Adults With Sickle Cell Disease: Protocol for the Cognitive Behavioral Therapy and Real-time Pain Management Intervention for Sickle Cell via Mobile Applications (CaRISMA) Study
Liles, Darla; Badawy, Sherif M.; Abebe, Kaleab Z.; Reichman, Charlotte A.; Checo, Grace; Hamm, Megan E.; Stinson, Jennifer; Lalloo, Chitra; Carroll, Patrick; Saraf, Santosh L.; Gordeuk, Victor R.; Desai, Payal; Shah, Nirmish; Trimnell, Cassandra; Jonassaint, Charles R. (2021) -
Exploring behaviors, treatment beliefs, and barriers to oral chemotherapy adherence among adult leukemia patients in a rural outpatient setting
Lea, C. Suzanne; Bohra, Sulochana; Moore, Tifanie; Passwater, Chelsea; Liles, Darla (2018-11-29)Objective: Adherence to oral chemotherapy is essential for patients with chronic myeloid leukemia (CML) and multiple myeloma (MM) to remain in remission. Few studies have used a Likert-type scale to measure medication ... -
The Impact of Locoregional Therapy in Nonmetastatic Inflammatory Breast Cancer: A Population-Based Study
Muzaffar, Mahvish; Johnson, Helen M.; Vohra, Nasreen A.; Liles, Darla; Wong, Jan H. (2018-06-03)Background. Inflammatory breast cancer (IBC) is a rare but most aggressive breast cancer subtype. The impact of locoregional therapy on survival in IBC is controversial. Methods. Patients with nonmetastatic IBC between ... -
Isolated neutropenia as a rare but serious adverse event secondary to immune checkpoint inhibition
Naqash, Abdul Rafeh; Appah, Ebenezer; Yang, Li V.; Muzaffar, Mahvish; Marie, Mona A.; Mccallen, Justin D.; Macherla, Shravanti; Liles, Darla; Walker, Paul R. (2019-07-05)Background Compared to conventional chemotherapy, Immune checkpoint inhibitors (ICI) are known to have a distinct toxicity profile commonly identified as immune-related adverse events (irAEs). These irAEs that are believed ...